NuVasive strengthens finance team with 3 appointments — 5 points

Spinal Tech

NuVasive appointed Lisa Pecora, Tristan Ribar and Marc Rosenbaum to finance roles.

Here are five points:

1. Lisa Pecora is now vice president of global commercial finance. In this role, she manages U.S. and international commercial finance functions.

2. Prior to this appointment, Ms. Pecora was executive vice president and CFO of Carling Communications. She also previously served as director of financial planning and analysis at CareFusion.

3. NuVasive also appointed Tristan Ribar as vice president of corporate finance and treasury.

4. Mr. Ribar most recently worked for Alere. He oversaw budgeting, forecasting, reporting and business analysis before Abbott Laboratories acquired Alere in 2017. He also previously served as director of investor relations at CareFusion.

5. Marc Rosenbaum will take over as corporate controller. He has been with NuVasive for four-plus years. Throughout his career he’s been in various senior accounting positions at Dura Pharmaceuticals, Elan Pharmaceuticals, Gen-Probe and Hologic.

"With these new leadership appointments, along with the rest of the finance team, we are building out the depth of the function through an excellent mix of finance and operations prowess as we focus on key areas to drive growth for NuVasive," said Raj Asarpota, NuVasive EVP and CFO.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers